HUTCHMED (LON:HCM) Stock Passes Below 200-Day Moving Average - Here's Why

Key Points

• Shares fell below the 200-day moving average: HUTCHMED traded under its 200-day MA of GBX 220.47, hitting as low as GBX 197.61 on Friday with about 14,986 shares traded.
• Valuation and balance-sheet snapshot: The company has a market capitalization of £1.70 billion and a low P/E of 3.73, with strong liquidity (current ratio 4.96, quick ratio 2.97) but a high debt-to-equity ratio of 7.91.
• Business profile: HUTCHMED is a China-focused novel drug discovery and commercial company with three approved oncology medicines (one also marketed in the U.S.) and is listed on Nasdaq, HKEX and the London AIM.

Shares of HUTCHMED (China) Limited (LON:HCM - ) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 220.47 and traded as low as GBX 197.61. HUTCHMED shares last traded at GBX 197.61, with a volume of 14,986 shares trading hands.

HUTCHMED Price Performance

The firm has a market capitalization of £1.70 billion, a P/E ratio of 3.73 and a beta of 0.51. The company has a current ratio of 4.96, a quick ratio of 2.97 and a debt-to-equity ratio of 7.91. The firm has a 50 day moving average price of GBX 215.76 and a 200-day moving average price of GBX 220.47.

HUTCHMED Company Profile

We are among the first global-focused novel drug discovery companies in China. Over the past two decades, we have established a fully integrated R&D platform with world-class discovery and development capabilities. Since inception, we have focused on bringing cancer drug candidates from in-house discovery to patients around the world, with our first three oncology medicines now approved marketed in China, the first of which is also marketed in the U.S. We have also developed a profitable commercial platform with deep pan-China market access, which manufactures, markets and distributes our novel oncology products, as well as prescription drugs and consumer health products in China. HUTCHMED is listed on the Nasdaq Global Select Market, the Stock Exchange of Hong Kong Limited and the London Stock Exchange's AIM market (Nasdaq/AIM:HCM; HKEX:13).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.